Subscribe
marbury-shutterstock-com
Marbury / Shutterstock.com
2 June 2016Big Pharma

NHS criticised over HIV drug wait

National Health Service (NHS) England has been criticised after announcing its decision that it will not be providing the HIV treatment Truvada, which enables pre-exposure prophylaxis (PrEP).

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Europe
UK Supreme Court shoots down NHS £220m drug patent suit
2 July 2021   The UK Government has failed to convince UK Supreme Court judges that Servier Laboratories misrepresented its blood pressure drugs patent in legal proceedings to block generic competitors from entering the market.
Big Pharma
NHS should finance HIV treatment PrEP, English High Court rules
2 August 2016   The English High Court has today said that National Health Service England should finance an important therapy used to treat patients suffering from HIV.


Editor's picks

Life sciences leaders recognised at LSPN Awards USA 2025
Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025

Editor's picks

Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025
Americas
LSPN: Using ‘the patentee’s friend’ in Section 112 claims
6 May 2025
Americas
Why US patent reform is ‘essential’ for US economic prosperity and security
29 April 2025
Europe
Meril v Edwards: Harmonisation of obviousness at the UPC and the EPO
24 April 2025
Americas
WIPR Diversity & Inclusion reveals Top 100 People in IP for 2025
24 April 2025
Big Pharma
AstraZeneca unit faces class-action suit over alleged Soliris monopoly
17 April 2025

More on this story

Europe
UK Supreme Court shoots down NHS £220m drug patent suit
2 July 2021   The UK Government has failed to convince UK Supreme Court judges that Servier Laboratories misrepresented its blood pressure drugs patent in legal proceedings to block generic competitors from entering the market.
Big Pharma
NHS should finance HIV treatment PrEP, English High Court rules
2 August 2016   The English High Court has today said that National Health Service England should finance an important therapy used to treat patients suffering from HIV.

More on this story

Europe
UK Supreme Court shoots down NHS £220m drug patent suit
2 July 2021   The UK Government has failed to convince UK Supreme Court judges that Servier Laboratories misrepresented its blood pressure drugs patent in legal proceedings to block generic competitors from entering the market.
Big Pharma
NHS should finance HIV treatment PrEP, English High Court rules
2 August 2016   The English High Court has today said that National Health Service England should finance an important therapy used to treat patients suffering from HIV.

More features

Life sciences leaders recognised at LSPN Awards USA 2025
UK-India trade deal is ‘a missed opportunity for UK pharma’, says industry body
LSPN: Counsel grapple with AI’s impact on training and critical thinking
'Nothing can stand in the way of our work': Ukraine resumes IP system
LSPN: Trump's policy storm causing chaos and confusion
Taylor Wessing expands in Europe with Paris team
LSPN: Using ‘the patentee’s friend’ in Section 112 claims
ResMed voids sleep apnoea tech patent at PTAB